|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
VX-745 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein] |
CTD |
PMID:28629242 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
decreases secretion multiple interactions |
ISO |
VX-745 results in decreased secretion of IL6 protein VX-745 inhibits the reaction [TNF protein results in increased secretion of IL6 protein] |
CTD |
PMID:12393542 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
decreases activity |
ISO |
VX-745 results in decreased activity of MAPK14 protein |
CTD |
PMID:28629242 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
VX-745 inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
VX-745 inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; VX-745 inhibits the reaction [TNF protein results in increased secretion of IL6 protein] |
CTD |
PMID:12393542 PMID:28629242 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases secretion |
ISO |
VX-745 results in decreased secretion of VEGFA protein |
CTD |
PMID:12393542 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|